after treatment for 8 weeks patients with ulcerative colitis showed morphologic remissions in 60 % of the 5-aminosalicylic acid group and in 53 % of the salazosulfapyridine group .
C0009324
ulcerative colitis
C0036078
salazosulfapyridine